These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7200655)
1. [Advances in transurethral resection of bladder carcinoma (author's transl)]. Bichler KH; Harzmann R; Flüchter SH; Erdmann W Urologe A; 1982 Jan; 21(1):3-8. PubMed ID: 7200655 [TBL] [Abstract][Full Text] [Related]
2. [Transurethral resection of bladder tumors--indication, technique and results (author's transl)]. Mauermayer W; Tauber R Urologe A; 1977 May; 16(3):185-9. PubMed ID: 878114 [TBL] [Abstract][Full Text] [Related]
3. [Clinical statistics of the bladder tumor--transurethral resection cases]. Uchida T; Ao T; Ikeda S; Yokoyama E; Kadowaki K; Shoji K; Koshiba K Hinyokika Kiyo; 1990 Sep; 36(9):1033-8. PubMed ID: 2239608 [TBL] [Abstract][Full Text] [Related]
4. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery. Al-Ali MA; Kashmoula DM; Haddad LF Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550 [TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529 [TBL] [Abstract][Full Text] [Related]
6. [The complications of transurethral resection of the bladder for tumor]. Chepurov AK; Nemenova AA Urol Nefrol (Mosk); 1996; (2):21-3. PubMed ID: 8677546 [TBL] [Abstract][Full Text] [Related]
7. TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer. Qureshi KN; Griffiths TR; Robinson MC; Marsh C; Roberts JT; Hall RR; Lunec J; Neal DE Clin Cancer Res; 1999 Nov; 5(11):3500-7. PubMed ID: 10589764 [TBL] [Abstract][Full Text] [Related]
8. [Endoscopic operations in invasive cancer of the urinary bladder]. Martov AG; Chernyshev IV; Sysoev PA; Gushchin BL; Shapovalov VV; Kozlov VV; Kornienko SI Urologiia; 2005; (2):35-9. PubMed ID: 15989025 [TBL] [Abstract][Full Text] [Related]
9. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? Herr HW; Donat SM; Dalbagni G J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005 [TBL] [Abstract][Full Text] [Related]
12. The value of a second transurethral resection in evaluating patients with bladder tumors. Herr HW J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743 [TBL] [Abstract][Full Text] [Related]
13. [The surgical treatment of patients with bladder cancer in middle and old age]. Tkachuk VN; al-Shukri SKh; Issa M Urol Nefrol (Mosk); 1997; (1):23-5. PubMed ID: 9123660 [TBL] [Abstract][Full Text] [Related]
14. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors. Chou EC; Lin AT; Chen KK; Chang LS Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642 [TBL] [Abstract][Full Text] [Related]
15. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia]. Karaguzhin SG; Merinov DS; Martov AG Urologiia; 2005; (5):17-21. PubMed ID: 16281833 [TBL] [Abstract][Full Text] [Related]
17. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315 [TBL] [Abstract][Full Text] [Related]
18. Long-term followup of all patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region. Holmäng S; Hedelin H; Anderström C; Johansson SL J Urol; 1997 Aug; 158(2):389-92. PubMed ID: 9224309 [TBL] [Abstract][Full Text] [Related]
19. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252 [TBL] [Abstract][Full Text] [Related]
20. The value of a second transurethral resection for T1 bladder cancer. Schwaibold HE; Sivalingam S; May F; Hartung R BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]